Cargando…

Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein

Parkinson’s disease is a progressive neurodegenerative disorder characterised by the accumulation of misfolded α-synuclein in selected brain regions, including the substantia nigra pars compacta (SNpc), where marked loss of dopaminergic neurons is also observed. Yet, the relationship between misfold...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKinnon, Chris, De Snoo, Mitchell L., Gondard, Elise, Neudorfer, Clemens, Chau, Hien, Ngana, Sophie G., O’Hara, Darren M., Brotchie, Jonathan M., Koprich, James B., Lozano, Andres M., Kalia, Lorraine V., Kalia, Suneil K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023783/ https://www.ncbi.nlm.nih.gov/pubmed/32059750 http://dx.doi.org/10.1186/s40478-020-0894-0

Ejemplares similares

Deep Brain Stimulation of the Medial Septal Nucleus Induces Expression of a Virally Delivered Reporter Gene in Dentate Gyrus
por: Fomenko, Anton, et al.
Publicado: (2020)

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62
por: Friesen, Erik L., et al.
Publicado: (2020)

Ubiquitinylation of α-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5)
por: Kalia, Lorraine V., et al.
Publicado: (2011)

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
por: O’Hara, Darren M., et al.
Publicado: (2020)

Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
por: Nim, Satra, et al.
Publicado: (2023)

Deep brain stimulation: potential for neuroprotection
por: McKinnon, Chris, et al.
Publicado: (2018)

Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members
por: Kapadia, Minesh, et al.
Publicado: (2020)

Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
por: Grotemeyer, Alexander, et al.
Publicado: (2023)

Chaperone-Based Therapies for Disease Modification in Parkinson's Disease
por: Friesen, Erik L., et al.
Publicado: (2017)

Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque
por: Koprich, James B., et al.
Publicado: (2016)

Direct detection of alpha synuclein oligomers in vivo
por: Dimant, Hemi, et al.
Publicado: (2013)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's Disease
por: Lang, Stefan, et al.
Publicado: (2023)

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans
por: Chen, Kevin S., et al.
Publicado: (2021)

Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death
por: De Snoo, Mitchell L., et al.
Publicado: (2019)

Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
por: Koprich, James B., et al.
Publicado: (2011)

C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
por: Mylvaganam, Sivakami, et al.
Publicado: (2021)

Non-steric-zipper models for pathogenic α-synuclein conformers
por: Schuman, Brock, et al.
Publicado: (2018)

Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α‐synuclein Parkinson's disease rat model
por: Musacchio, Thomas, et al.
Publicado: (2017)

Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin–proteasome system
por: McKinnon, Chris, et al.
Publicado: (2015)

Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
por: Koprich, James B, et al.
Publicado: (2010)

α-Synuclein Decreases the Abundance of Proteasome Subunits and Alters Ubiquitin Conjugates in Yeast
por: Popova, Blagovesta, et al.
Publicado: (2021)

Merging DBS with viral vector or stem cell implantation: “hybrid” stereotactic surgery as an evolution in the surgical treatment of Parkinson’s disease
por: Rowland, Nathan C, et al.
Publicado: (2016)

27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons
por: Schommer, Jared, et al.
Publicado: (2018)

Proteasome impairment by α-synuclein
por: Zondler, Lisa, et al.
Publicado: (2017)

The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates
por: Mukherjee, Tapas, et al.
Publicado: (2020)

Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
por: Badr, Mohammad, et al.
Publicado: (2022)

Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells
por: Chau, K.Y., et al.
Publicado: (2010)

α-Synuclein–induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms
por: Chiu, Wei-Hua, et al.
Publicado: (2021)

Limiting the power of p53 through the ubiquitin proteasome pathway
por: Pant, Vinod, et al.
Publicado: (2014)

Deep-Brain Stimulation for Essential Tremor and Other Tremor Syndromes: A Narrative Review of Current Targets and Clinical Outcomes
por: Iorio-Morin, Christian, et al.
Publicado: (2020)

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
por: Ip, Chi Wang, et al.
Publicado: (2017)

Physiological mechanisms of thalamic ventral intermediate nucleus stimulation for tremor suppression
por: Milosevic, Luka, et al.
Publicado: (2018)

Cavitation Feedback Control of Focused Ultrasound Blood-Brain Barrier Opening for Drug Delivery in Patients with Parkinson’s Disease
por: Huang, Yuexi, et al.
Publicado: (2022)

A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
por: Henrich, Martin Timo, et al.
Publicado: (2018)

Beta band oscillations in the motor thalamus are modulated by visuomotor coordination in essential tremor patients
por: Basha, Diellor, et al.
Publicado: (2023)

A Primer on Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Medically Refractory Epilepsy
por: Lee, Eun Jung, et al.
Publicado: (2019)

Salidroside Promotes the Pathological α-Synuclein Clearance Through Ubiquitin-Proteasome System in SH-SY5Y Cells
por: Li, Tao, et al.
Publicado: (2018)

The ubiquitin-proteasome pathway in cancer.
por: Spataro, V., et al.
Publicado: (1998)

The ubiquitin proteasome system in neuropathology
por: Lehman, Norman L.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_o3rnd4omvvetotrnjsqv8btrgv